These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 11560969)
1. The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia. Arteaga CL J Clin Oncol; 2001 Sep; 19(18 Suppl):32S-40S. PubMed ID: 11560969 [TBL] [Abstract][Full Text] [Related]
2. Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia. Arteaga CL Semin Oncol; 2002 Oct; 29(5 Suppl 14):3-9. PubMed ID: 12422308 [TBL] [Abstract][Full Text] [Related]
3. Rational bases for the development of EGFR inhibitors for cancer treatment. Bianco R; Gelardi T; Damiano V; Ciardiello F; Tortora G Int J Biochem Cell Biol; 2007; 39(7-8):1416-31. PubMed ID: 17596994 [TBL] [Abstract][Full Text] [Related]
9. Interaction of the neu/p185 and EGF receptor tyrosine kinases: implications for cellular transformation and tumor therapy. Dougall WC; Qian X; Greene MI J Cell Biochem; 1993 Sep; 53(1):61-73. PubMed ID: 7901229 [TBL] [Abstract][Full Text] [Related]
10. The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors. Rowinsky EK Annu Rev Med; 2004; 55():433-57. PubMed ID: 14746530 [TBL] [Abstract][Full Text] [Related]